Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns 212,014 shares […]